PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis

Ming Liu, Xiaomei Liao, Fangchao Wang, Pengqing Jiao, Zhongkai Wang · 2026

Read PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis by Ming Liu, Xiaomei Liao, Fangchao Wang, Pengqing Jiao, Zhongkai Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351846.txt.

Description

Ming Liu and colleagues found a protein that helps stomach cancer cells survive a common chemotherapy drug. The drug is known as 5-FU. The protein is called PTPRE, and it runs high in gastric tumors. The team studied it in cancer cells and in mouse tumor grafts. They traced how it protects the cells from a form of iron-driven cell death.

The protein switches on a chain of signals inside the cell. That chain ends at a second protein, TRIB3. With the chain active, the iron-driven death route stays shut. The drug then loses one of its ways to kill, and resistance sets in. Blocking the chain could hand the drug its power back. The work names each link, which is what drug developers need first.

Catalog record

CREATORMing Liu, Xiaomei Liao, Fangchao Wang, Pengqing Jiao, Zhongkai Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28389
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0351846

Browse the full library · About the Tower of Babel